期刊
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
卷 63, 期 11, 页码 -出版社
AMER SOC MICROBIOLOGY
DOI: 10.1128/AAC.01024-19
关键词
dalbavancin; lung epithelial lining fluid; pharmacokinetics; pharmacodynamics; pneumonia
资金
- Durata Therapeutics
- Allergan plc.
Dalbavancin is a lipoglycopeptide antibiotic with a prolonged half-life. A phase 1 study assessed dalbavancin levels in epithelial lining fluid (ELF) in 35 healthy adults using ELF bronchial microsampling up to 168 h after administration of 1,500 mg dalbavancin. The penetration of dalbavancin into ELF was 36%. ELF levels of dalbavancin exceeded the MIC(90)s of Streptococcus pneumoniae and Staphylococcus aureus for >= 7 days.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据